ART initiation among the four calendar groups
| 2014/03– 2015/03 (n=201) | 2015/04– 2016/0323 (n=190) | 2016/04– 2017/03 (n=117) | 2017/04– 2018/07 (n=123) | P value | |
| ART initiation, n (%) | 187 (93.0) | 177 (93.2) | 108 (92.3) | 119 (96.7) | 0.283 |
| Rapid ART initiation, n (%) | 68 (33.8) | 101 (53.2) | 63 (53.8) | 84 (68.3) | <0.001 |
| Third agent of ART used | |||||
| nNRTI, n (%) | 171 (91.4) | 166 (93.8) | 85 (78.7) | 36 (30.3) | <0.001 |
| PI, n (%) | 4 (2.1) | 2 (1.1) | 0 | 0 | 0.265 |
| InSTI, n (%) | 11 (5.9) | 9 (5.1) | 23 (21.3) | 83 (69.8) | <0.001 |
ART, antiretroviral therapy; nNRTI, non-nucleoside reverse-transcriptase inhibitors; PI, protease inhibitor; InSTI, integrase strand transfer inhibitor